ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
RXi and Karolinska Institutet target solid tumour therapy
pharmaceutical-technology
August 17, 2018US-based biotechnology company RXi Pharmaceuticals has formed a research alliance with the Karolinska Institutet in Stockholm, Sweden, to develop and improve immuno-oncology treatments for solid tumours. -
RXi Receives Patent from USPTO
americanpharmaceuticalreview
May 18, 2018RXi Pharmaceuticals has been granted a patent from the United States Patent and Trademark Office (USPTO) for the methods of use of sd-rxRNAs targeting Connective Tissue Growth Factor (CTGF) for the treatment or prevention of fibrotic disorders,
Pharma Sources Insight January 2025
